Factset Research Systems Inc: Form 10-Q for the period ended Feb 29, 2020
Filed with the SEC on Apr 9, 2020 and accepted by EDGAR at Apr 9, 2020, 06:56 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-02-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-12-01 to 2020-02-29 | $369.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2019-09-01 to 2020-02-29 | $736.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months2019-12-01 to 2020-02-29 | $87.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2019-09-01 to 2020-02-29 | $175.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-12-01 to 2020-02-29 | $106.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-09-01 to 2020-02-29 | $219.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-12-01 to 2020-02-29 | $14.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-09-01 to 2020-02-29 | $29.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-12-01 to 2020-02-29 | $88.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-09-01 to 2020-02-29 | $182.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-12-01 to 2020-02-29 | $2.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-09-01 to 2020-02-29 | $4.73 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-12-01 to 2020-02-29 | $2.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-09-01 to 2020-02-29 | $4.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-12-01 to 2020-02-29 | 38,576,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-09-01 to 2020-02-29 | 38,582,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-09-01 to 2020-02-29 | $195.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2019-12-01 to 2020-02-29 | $25.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2019-09-01 to 2020-02-29 | $51.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2019-09-01 to 2020-02-29 | $54.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2019-09-01 to 2020-02-29 | $158.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-02-29 | $343.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-02-29 | $601.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-02-29 | $1.83bn | us-gaap:Assets |
| Current liabilities | At period end2020-02-29 | $228.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-02-29 | $1.11bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-02-29 | $574.3m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2020-02-29 | $716.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001013237-20-000061. Last ingested by Listed: Nov 11, 2026, 01:02 ET. Listed shows no prices and gives no investment advice.